Null-type SH2B3 mutations are potential drivers in a subset of Ph-negative myeloproliferative neoplasms

Am J Hematol. 2024 Sep;99(9):1841-1844. doi: 10.1002/ajh.27411. Epub 2024 Jun 25.

¹ Division of Hematopathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
² Department of Pathology, Geisinger Medical Center, Danville, Pennsylvania, USA.
³ ARUP Laboratories, Salt Lake City, Utah, USA.
⁴ Department of Laboratory Medicine and Pathology, Mayo Clinic, Jacksonville, Florida, USA.
⁵ Department of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
⁶ Division of Laboratory Genetics and Genomics, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.

No abstract available

Publication types